The therapeutic potential and mechanisms of action of quercetin in relation to lipopolysaccharide-induced sepsis in vitro and in vivo

PLoS ONE

Volumn 8, Issue 11, 2013, Pages

  Chang, Yu Cheng ^a   Tsai, Ming Han ^a   Sheu, Wayne Huey Herng ^b   Hsieh, Shu Chen ^c   Chiang, An Na ^a  

^a NATIONAL YANG MING UNIVERSITY   (Taiwan)

^b TAICHUNG VETERANS GENERAL HOSPITAL   (Taiwan)

^c NATIONAL TAIWAN UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIUM LIPOPOLYSACCHARIDE; I KAPPA B KINASE ALPHA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1BETA; PROTEIN KINASE B; QUERCETIN; STRESS ACTIVATED PROTEIN KINASE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DOSE RESPONSE; DRUG PROTEIN BINDING; ENDOTOXEMIA; IN VITRO STUDY; IN VIVO STUDY; INFLAMMATION; INTRACELLULAR SIGNALING; LETHALITY; MACROPHAGE; MALE; MOUSE; NONHUMAN; PROTEIN PHOSPHORYLATION; SEPSIS; TREATMENT OUTCOME;

ANIMALS; CELL LINE; DISEASE MODELS, ANIMAL; ENZYME ACTIVATION; I-KAPPA B KINASE; INTERLEUKIN-1BETA; JNK MITOGEN-ACTIVATED PROTEIN KINASES; LIPOPOLYSACCHARIDES; MACROPHAGES; MALE; MICE; NF-KAPPA B; PHOSPHORYLATION; PROTO-ONCOGENE PROTEINS C-AKT; QUERCETIN; SEPSIS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84896712417     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0080744     Document Type: Article

References (35)

1. de Jong HK, van der Poll T, Wiersinga WJ (2010) The systemic pro-inflammatory response in sepsis. J Innate Immun 2: 422-430. doi:10.1159/000316286. PubMed: 20530955.
2. Beutler B, Rietschel ET (2003) Innate immune sensing and its roots: the story of endotoxin. Nat Rev Immunol 3: 169-176. doi:10.1038/nri1004. PubMed: 12563300. (Pubitemid 37328694)
3. Doi K, Leelahavanichkul A, Yuen PS, Star RA (2009) Animal models of sepsis and sepsis-induced kidney injury. J Clin Invest 119: 2868-2878. doi:10.1172/JCI39421. PubMed: 19805915.
4. Riedemann NC, Guo RF, Ward PA (2003) The enigma of sepsis. J Clin Invest 112: 460-467. doi:10.1172/JCI200319523. PubMed: 12925683. (Pubitemid 38056327)
5. Yuan GJ, Gong ZJ, Sun XM, Zheng SH, Li X (2006) Tea polyphenols inhibit expressions of iNOS and TNF-α and prevent lipopolysaccharide-induced liver injury in rats. Hepatobiliary Pancreat Dis Int 5: 262-267. PubMed: 16698588.
6. Jung WK, Choi I, Lee DY, Yea SS, Choi YH et al. (2008) Caffeic acid phenethyl ester protects mice from lethal endotoxin shock and inhibits lipopolysaccharide-induced cyclooxygenase-2 and inducible nitric oxide synthase expression in RAW 264.7 macrophages via the p38/ERK and NF-κB pathways. Int J Biochem Cell Biol 40: 2572-2582. doi:10.1016/j.biocel.2008.05.005. PubMed: 18571461.
7. Peluso MR (2006) Flavonoids attenuate cardiovascular disease, inhibit phosphodiesterase, and modulate lipid homeostasis in adipose tissue and liver. Exp Biol Med (Maywood) 231: 1287-1299. PubMed: 16946397.
8. Bischoff SC (2008) Quercetin: potentials in the prevention and therapy of disease. Curr Opin Clin Nutr Metab Care 11: 733-740. doi:10.1097/MCO. 0b013e32831394b8. PubMed: 18827577.
9. Boots AW, Haenen GR, Bast A (2008) Health effects of quercetin: from antioxidant to nutraceutical. Eur J Pharmacol 585: 325-337. doi:10.1016/j. ejphar.2008.03.008. PubMed: 18417116.
10. Comalada M, Camuesco D, Sierra S, Ballester I, Xaus J et al. (2005) In vivo quercitrin anti-inflammatory effect involves release of quercetin, which inhibits inflammation through down-regulation of the NF-κB pathway. Eur J Immunol 35: 584-592. doi:10.1002/eji.200425778. PubMed: 15668926. (Pubitemid 40331335)
11. Bournival J, Plouffe M, Renaud J, Provencher C, Martinoli MG (2012) Quercetin and sesamin protect dopaminergic cells from MPP+-induced neuroinflammation in a microglial (N9)-neuronal (PC12) coculture system. Oxid Med Cell Longev 2012: 921941.
12. Guha M, Mackman N (2002) The phosphatidylinositol 3-kinase-Akt pathway limits lipopolysaccharide activation of signaling pathways and expression of inflammatory mediators in human monocytic cells. J Biol Chem 277: 32124-32132. doi:10.1074/jbc.M203298200. PubMed: 12052830. (Pubitemid 34969025)
13. Lu YC, Yeh WC, Ohashi PS (2008) LPS/TLR4 signal transduction pathway. Cytokine 42: 145-151. doi:10.1016/j.cyto.2008.01.006. PubMed: 18304834.
14. Ghosh S, Hayden MS (2008) New regulators of NF-κB in inflammation. Nat Rev Immunol 8: 837-848. doi:10.1038/nri2423. PubMed: 18927578.
15. Jung J, Ko SH, Yoo do Y, Lee JY, Kim YJ et al. (2012) 5,7-Dihydroxy-3,4,6-trimethoxyflavone inhibits intercellular adhesion molecule 1 and vascular cell adhesion molecule 1 via the Akt and nuclear factor-κB-dependent pathway, leading to suppression of adhesion of monocytes and eosinophils to bronchial epithelial cells. Immunology 137: 98-113. doi:10.1111/j.1365-2567.2012.03618.x. PubMed: 22862554.
16. Park YM, Won JH, Yun KJ, Ryu JH, Han YN et al. (2006) Preventive effect of Ginkgo biloba extract (GBB) on the lipopolysaccharide-induced expressions of inducible nitric oxide synthase and cyclooxygenase-2 via suppression of nuclear factor-κB in RAW 264.7 cells. Biol Pharm Bull 29: 985-990. doi:10.1248/bpb.29.985. PubMed: 16651732.
17. Cargnello M, Roux PP (2011) Activation and function of the MAPKs and their substrates, the MAPK-activated protein kinases. Microbiol Mol Biol Rev 75: 50-83. doi:10.1128/MMBR.00031-10. PubMed: 21372320.
18. Hsu CC, Lien JC, Chang CW, Chang CH, Kuo SC et al. (2013) Yuwen02f1 suppresses LPS-induced endotoxemia and adjuvant-induced arthritis primarily through blockade of ROS formation, NFκB and MAPK activation. Biochem Pharmacol 85: 385-395. doi:10.1016/j.bcp.2012.11.002. PubMed: 23142712.
19. Jiang SJ, Hsu SY, Deng CR, Huang HC, Liu SL et al. (2013) Dextromethorphan attenuates LPS-induced adhesion molecule expression in human endothelial cells. Microcirculation 20: 190-201. doi:10.1111/micc.12024. PubMed: 23140507.
20. Tang D, Kang R, Xiao W, Zhang H, Lotze MT et al. (2009) Quercetin prevents LPS-induced high-mobility group box 1 release and proinflammatory function. Am J Respir Cell Mol Biol 41: 651-660. doi:10.1165/rcmb.2008-0119OC. PubMed: 19265175.
21. Chong DL, Sriskandan S (2011) Pro-inflammatory mechanisms in sepsis. Contrib Microbiol 17: 86-107. doi:10.1159/000324022. PubMed: 21659748.
22. Riedemann NC, Guo RF, Ward PA (2003) Novel strategies for the treatment of sepsis. Nat Med 9: 517-524. doi:10.1038/nm0503-517. PubMed: 12724763. (Pubitemid 36597096)
23. Cho SY, Park SJ, Kwon MJ, Jeong TS, Bok SH et al. (2003) Quercetin suppresses proinflammatory cytokines production through MAP kinases and NF-κB pathway in lipopolysaccharide-stimulated macrophage. Mol Cell Biochem 243: 153-160. doi:10.1023/A:1021624520740. PubMed: 12619901.
24. Peet GW, Li J (1999) IκB kinases α and β show a random sequential kinetic mechanism and are inhibited by staurosporine and quercetin. J Biol Chem 274: 32655-32661. doi:10.1074/jbc.274.46.32655. PubMed: 10551820. (Pubitemid 129535292)
25. Chen JC, Ho FM, Pei-Dawn Lee C, Chen CP, Jeng KC et al. (2005) Inhibition of iNOS gene expression by quercetin is mediated by the inhibition of IκB kinase, nuclear factor-κB and STAT1, and depends on heme oxygenase-1 induction in mouse BV-2 microglia. Eur J Pharmacol 521: 9-20. doi:10.1016/j.ejphar.2005.08.005. PubMed: 16171798. Available online at: doi:10.1016/j.ejphar.2005.08.005 Available online at: PubMed: 16171798
26. Pianetti S, Arsura M, Romieu-Mourez R, Coffey RJ, Sonenshein GE (2001) Her-2/neu overexpression induces NF-κB via a PI3-kinase/Akt pathway involving calpain-mediated degradation of IκB-α that can be inhibited by the tumor suppressor PTEN. Oncogene 20: 1287-1299. doi:10.1038/sj.onc.1204257. PubMed: 11313873. (Pubitemid 32269934)
27. Hennessy BT, Smith DL, Ram PT, Lu Y, Mills GB (2005) Exploiting the PI3K/AKT pathway for cancer drug discovery. Nat Rev Drug Discov 4: 988-1004. doi:10.1038/nrd1902. PubMed: 16341064.
28. Julien S, Puig I, Caretti E, Bonaventure J, Nelles L et al. (2007) Activation of NF-κB by Akt upregulates Snail expression and induces epithelium mesenchyme transition. Oncogene 26: 7445-7456. doi:10.1038/sj.onc. 1210546. PubMed: 17563753. (Pubitemid 350158710)
29. Hong KO, Kim JH, Hong JS, Yoon HJ, Lee JI et al. (2009) Inhibition of Akt activity induces the mesenchymal-to-epithelial reverting transition with restoring E-cadherin expression in KB and KOSCC-25B oral squamous cell carcinoma cells. J Exp Clin Cancer Res 28: 28. doi:10.1186/1756-9966-28-28. PubMed: 19243631.
30. Choi BH, Kim CG, Lim Y, Shin SY, Lee YH (2008) Curcumin down-regulates the multidrug-resistance mdr1b gene by inhibiting the PI3K/Akt/NFκB pathway. Cancer Lett 259: 111-118. doi:10.1016/j.canlet.2007.10.003. PubMed: 18006147. (Pubitemid 350235095)
31. Li X, Syrovets T, Simmet T (2012) The serine protease plasmin triggers expression of the CC-chemokine ligand 20 in dendritic cells via Akt/NF- κB-dependent pathways. J Biomed Biotechnol 2012: 186710.
32. Gulati N, Laudet B, Zohrabian VM, Murali R, Jhanwar-Uniyal M (2006) The antiproliferative effect of Quercetin in cancer cells is mediated via inhibition of the PI3K-Akt/PKB pathway. Anticancer Res 26: 1177-1181. PubMed: 16619521.
33. Zhang D, Gao X, Wang Q, Qin M, Liu K et al. (2013) Kakkalide ameliorates endothelial insulin resistance by suppression of reactive oxygen species (ROS)-associated inflammation. J Diabetes 5: 13-24. doi:10.1111/1753-0407.12017. PubMed: 23190749.
34. Bennett BL, Sasaki DT, Murray BW, O'Leary EC, Sakata ST et al. (2001) SP600125, an anthrapyrazolone inhibitor of Jun N-terminal kinase. Proc Natl Acad Sci U S A 98: 13681-13686. doi:10.1073/pnas.251194298. PubMed: 11717429. (Pubitemid 33115958)
35. Nguyen MT, Favelyukis S, Nguyen AK, Reichart D, Scott PA et al. (2007) A subpopulation of macrophages infiltrates hypertrophic adipose tissue and is activated by free fatty acids via Toll-like receptors 2 and 4 and JNK-dependent pathways. J Biol Chem 282: 35279-35292. doi:10.1074/jbc.M706762200. PubMed: 17916553. (Pubitemid 350232441)